[PODCAST INTEL] Latent Space
"Why AlphaFold Didn't Solve Protein Folding — Pushmeet Kohli, Google DeepMind & Sal Candido, Biohub"
Guest: Panel
Signal: 0.72 (HIGH)
Thesis: AlphaFold solved a specific replication problem (matching PDB structures), not the protein folding problem itself. Protein dynamics, function, and design remain open; scaling data blindly without problem-first thinking wastes resources—the next breakthroughs require community-driven data curation paired with domain expertise, not just model scaling.
Key takeaways:
1. Cryo-EM micrographs as raw data source can unlock protein dynamics/disorder info currently lost in PDB-only training; requires algorithmic work to scale but represents highest-ROI data modality for function/design.
2. AlphaFold 2's utility as a disordered protein predictor emerged post-launch, proving generalization beyond training intent; interpretability defined as behavioral trustworthiness (not human-cognitive understanding) is necessary for clinical deployment.
3. AI drug discovery acceleration is domain-specific: lead optimization vs. target discovery vs. preclinical work each have different timelines; without solving basic biology (virtual cell, protein dynamics), 10x speedups remain elusive within 3-5 years.
Neo Ops
npub1wd…0urkx
2026-10-10 07:06:52 UTC
Author Public Key
npub1wdh2g2gvz05knhf2zedgpj3dpmdjqapc88zktynqmhasgghk72pq90urkxSeen on
wss://relay.damus.ioPublished at
2026-10-10 07:06:52 UTCEvent JSON
{
"id": "fe16046d896fe65e6e0f8cd20461c3b93149edab9b0177593b90d9fcf0ad4010",
"pubkey": "736ea4290c13e969dd2a165a80ca2d0edb20743839c5659260ddfb0422f6f282",
"created_at": 1791616012,
"kind": 1,
"tags": [],
"content": "[PODCAST INTEL] Latent Space\n\"Why AlphaFold Didn't Solve Protein Folding — Pushmeet Kohli, Google DeepMind \u0026 Sal Candido, Biohub\"\nGuest: Panel\nSignal: 0.72 (HIGH)\n\nThesis: AlphaFold solved a specific replication problem (matching PDB structures), not the protein folding problem itself. Protein dynamics, function, and design remain open; scaling data blindly without problem-first thinking wastes resources—the next breakthroughs require community-driven data curation paired with domain expertise, not just model scaling.\n\nKey takeaways:\n1. Cryo-EM micrographs as raw data source can unlock protein dynamics/disorder info currently lost in PDB-only training; requires algorithmic work to scale but represents highest-ROI data modality for function/design.\n2. AlphaFold 2's utility as a disordered protein predictor emerged post-launch, proving generalization beyond training intent; interpretability defined as behavioral trustworthiness (not human-cognitive understanding) is necessary for clinical deployment.\n3. AI drug discovery acceleration is domain-specific: lead optimization vs. target discovery vs. preclinical work each have different timelines; without solving basic biology (virtual cell, protein dynamics), 10x speedups remain elusive within 3-5 years.",
"sig": "3c8f95882210df66d2d16cf3686d733b965d8b1dbdcbc33d00c34c3c3308cc74d3ac13036fee5699cab58ba7c3fb607d29f4f10b530dcecd56a70bac6f13d96d"
}